Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

Shenzhen Stock Exchange 002932.SZ

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Dividend Yield on January 14, 2025: 14.46%

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Dividend Yield is 14.46% on January 14, 2025, a 32.94% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 52-week high Dividend Yield is 16.16% on February 05, 2024, which is 11.76% above the current Dividend Yield.
  • Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 52-week low Dividend Yield is 10.87% on January 15, 2024, which is -24.78% below the current Dividend Yield.
  • Wuhan Easy Diagnosis Biomedicine Co.,Ltd. average Dividend Yield for the last 52 weeks is 13.46%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
Shenzhen Stock Exchange: 002932.SZ

Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

CEO Ms. Chen Li Li
IPO Date July 10, 2018
Location China
Headquarters Wuhan Optics Valley International Biomed
Employees 1,547
Sector Health Care
Industries
Description

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.

Similar companies

300677.SZ

Intco Medical Technology Co., Ltd.

USD 3.37

3.57%

002030.SZ

Daan Gene Co., Ltd.

USD 0.79

3.04%

688298.SS

Zhejiang Orient Gene Biotech Co., Ltd.

USD 3.93

2.90%

688068.SS

Beijing Hotgen Biotech Co., Ltd.

USD 9.57

0.77%

002432.SZ

Andon Health Co., Ltd.

USD 5.45

2.10%

StockViz Staff

January 15, 2025

Any question? Send us an email